Company
InGel
Engineered cell therapy platform to treat retinal degeneration.
Also known as INGEL THERAPEUTICS, INC.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Legal name
- INGEL THERAPEUTICS, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Engineered cell therapy platform to treat retinal degeneration.
Funding snapshot
- Total raised
- $350KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $350K2022-07-06
Funding rounds
- Round, 2022
- $350K2022-07-06, SEC form D sold, 4 investors
Products
- Other
- Regenesis
Loading relationship preview